Emma James

Ms. Emma James

University of Wollongong
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EJEmma James
Emma James
Eva Tomaskovic-CrookEva Tomaskovic-Crook
Eva Tomaskovic-Crook
Jeremy CrookJeremy Crook
Jeremy Crook
The regenerative capacity of cardiomyocytes is insufficient to functionally recover damaged tissue, and as such, ischaemic heart disease forms the largest proportion of cardiovascular associated deaths. Human-induced pluripotent stem cells (hiPSCs) have enormous potential for developing patient specific cardiomyocytes for modelling heart disease, patient-based cardiac toxicity testing and potentially replacement therapy. However, traditional protocols for hiPSC-derived cardiomyocytes yield mixed populations of atrial, ventricular and nodal-like cells with immature cardiac properties. New insights gleaned from embryonic heart development have progressed the precise production of subtype-specific hiPSC-derived cardiomyocytes; however, their physiological immaturity severely limits their utility as model systems and their use for drug screening and cell therapy. The long-entrenched challenges in this field are being addressed by innovative bioengingeering technologies that incorporate biophysical, biochemical and more recently biomimetic electrical cues, with the latter having the potential to be used to both direct hiPSC differentiation and augment maturation and the function of derived cardiomyocytes and cardiac tissues by mimicking endogenous electric fields.

1 January 2020
Verified
Book Chapter
Closed access
Eva Tomaskovic-CrookEva Tomaskovic-Crook
Eva Tomaskovic-Crook
SHSarah L. Higginbottom
Sarah L. Higginbottom
EJEmma James
Emma James
SRSamuel J.C. Rathbone
Samuel J.C. Rathbone
Jeremy CrookJeremy Crook
Jeremy Crook